FrancophonIA/ELRC3.0 huggingface dataset:
English: SVR after treatment of chronic HCV with non-pegylated interferon alfa-2b with ribavirin results in long-term clearance of the virus providing resolution of the hepatic infection and clinical 'cure' from chronic HCV.
Croatian: Trajan virološki odgovor nakon liječenja kroničnog hepatitisa C nepegiliranim interferonom alfa-2b i ribavirinom rezultira dugoročnom eliminacijom virusa, što omogućuje rezoluciju infekcije jetre i kliničko "ozdravljenje" od kroničnog hepatitisa C.
English: This medicine in combination with an alpha interferon product may also cause: aplastic anaemia, pure red cell aplasia (a condition where the body stopped or reduced the production of red blood cells); this causes severe anaemia, symptoms of which would include unusual tiredness and a lack of energy,
Croatian: Ovaj lijek u kombinaciji s interferonom alfa također može prouzročiti: aplastičnu anemiju, izoliranu aplaziju crvene krvne loze (stanje u kojem organizam prestaje proizvoditi ili smanjeno proizvodi crvene krvne stanice).
English: Haemolysis
Croatian: Nuspojave
English: Table 3 Management of Adverse Reactions
Croatian: Tablica 3 Zbrinjavanje nuspojava
English: Cardiac ischaemia*
Croatian: srčana ishemija*
English: Laboratory values for HCV/HIV co-infected patients
Croatian: Laboratorijske vrijednosti u bolesnika s istodobnom infekcijom HCV-om i HIV-om
English: Packs of 14, 28, 42, 56, 84, 112, 140 and 168 tablets Not all pack sizes may be marketed.
Croatian: Pakiranja od 14, 28, 42, 56, 84, 112, 140 i 168 tableta
English: If you are a HCV/HIV co-infected adult patient receiving anti-HIV treatment, the addition of this medicine and peginterferon alfa-2b may increase your risk of worsening liver function combined antiretroviral therapy (cART) and increase your risk of lactic acidosis, liver failure, and blood abnormalities development (reduction in number of red blood cells which carry oxygen, certain white blood cells that fight infection, and blood clotting cells called platelets) (NRTI).
Croatian: HIV-a, dodavanje ovog lijeka i peginterferona alfa-2b može povećati rizik od pogoršanja funkcije jetre kombiniranom antiretrovirusnom terapijom (cART) i povećati rizik od laktacidoze, zatajenja jetre i razvoja poremećaja krvne slike (smanjenja broja crvenih krvnih stanica koje prenose kisik, određenih bijelih krvnih stanica koje pomažu u borbi protiv infekcije i krvnih pločica koje se zovu trombociti i odgovorne su za zgrušavanje krvi) (NRTI).
English: Lower respiratory tract infection
Croatian: infekcija donjih dišnih puteva rijetko:
English: Please read the “Possible side effects” section of the Package Leaflet for the other medicines used in combination with Ribavirin Teva Pharma B.V..
Croatian: Molimo pročitajte i dio "Moguće nuspojave" u Uputama o lijeku za druge lijekove koji se primjenjuju u kombinaciji s lijekom Ribavirin Teva Pharma B.V.
English: delusions, upper and lower respiratory tract infection, inflammation of the pancreas, severe rashes which may be associated with blisters in the mouth, nose, eyes and other mucosal membranes (erythema multiforme, Stevens Johnson syndrome), toxic epidermal necrolysis (blistering and peeling of the top layer of skin).
Croatian: To uzrokuje tešku anemiju čiji simptomi uključuju neuobičajeni umor i manjak energije, deluzije, infekciju gornjih i donjih dišnih puteva, upalu gušterače, teške osipe koji mogu biti popraćeni mjehurima u ustima, nosu, očima i drugim sluznicama (multiformni eritem, Stevens-Johnsonov sindrom), toksičnu epidermalnu nekrolizu (mjehurići i ljuštenje gornjeg sloja kože).
English: Table 1 Ribavirin Teva Pharma B.V. dose based on body weight when used in combination with interferon alfa-2b in paediatric patients
Croatian: Tablica 1 Doza lijeka Ribavirin Teva Pharma B.V. zasniva se na tjelesnoj težini pri primjeni u kombinaciji s interferonom alfa-2b u pedijatrijskih bolesnika Težina bolesnika (kg)
English: An increase in uric acid and indirect bilirubin values associated with haemolysis was observed in some patients treated with Ribavirin Teva Pharma B.V. used in combination with peginterferon alfa-2b or interferon alfa-2b in clinical trials, but values returned to baseline levels by four weeks after the end of therapy.
Croatian: U nekih bolesnika liječenih lijekom Ribavirin Teva Pharma B.V. u kombinaciji s peginterferonom alfa-2b ili interferonom alfa-2b u kliničkim ispitivanjima primijećeno je povišenje vrijednosti mokraćne kiseline i indirektnog bilirubina povezano s hemolizom, no te su se vrijednosti vratile na početne najkasnije 4 tjedna po završetku liječenja.
English: Pharmachemie B.V. Swensweg 5
Croatian: Pharmachemie B.V.
English: This medicine must not be used without interferon alfa-2b, i.e.
Croatian: Ovaj lijek se ne smije koristiti bez interferona alfa-2b, odnosno Ribavirin Teva Pharma B.V. se ne smije uzimati sam.
English: MANUFACTURER RESPONSIBLE FOR BATCH RELEASE
Croatian: PROIZVOĐAČI ODGOVORNI ZA PUŠTANJE SERIJE LIJEKA U PROMET
English: Ribavirin in combination with interferon alfa-2b
Croatian: Ribavirin u kombinaciji s interferonom alfa-2b
English: OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION
Croatian: OSTALI UVJETI I ZAHTJEVI ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET • Periodička izvješća o neškodljivosti
English: What you need to know before you use Ribavirin Teva Pharma B.V. Do not take Ribavirin Teva Pharma B.V.
Croatian: Što morate znati prije nego počnete uzimati Ribavirin Teva Pharma B.V.
English: The patient was observed for two days in the emergency room, during which time no adverse reaction from the overdose was noted.
Croatian: Bolesnik je bio pod liječničkim nadzorom dva dana u jedinici intenzivne skrbi.
English: Please refer to the corresponding SmPC of medicinal products used in combination with Ribavirin Teva Pharma B.V. for contraindications specific to these products.
Croatian: Molimo pročitajte odgovarajuće Sažetke opisa svojstava lijeka za lijekove koji se primjenjuju u kombinaciji s lijekom Ribavirin Teva Pharma B.V. za kontraindikacije specifične za te lijekove.
English: Hepatic function
Croatian: Funkcija bubrega
English: Teva Pharma, S.L.U Tél: +(34) 91 387 32 80
Croatian: Tél: +(34) 91 387 32 80
English: HCV/HIV Co-infection
Croatian: Istodobna infekcija HCV-om i HIV-om
English: Ribavirin in combination with peginterferon alfa-2b
Croatian: Ribavirin u kombinaciji s peginterferonom alfa-2b
English: Psoriasis, aggravated psoriasis, eczema, photosensitivity reaction, maculopapular rash, erythematous rash, night sweats, hyperhidrosis, dermatitis, acne, furuncule, erythema, urticaria, skin disorder, bruise, sweating increased, abnormal hair texture, nail disorder*
Croatian: alopecija, pruritus, suha koža, osip psorijaza, pogoršanje psorijaze, ekcem, reakcija fotosenzitivnosti, makulopapularni osip, eritematozni osip, noćno znojenje, hiperhidroza, dermatitis, akne, furunkul, eritem, urtikarija, poremećaj kože, modrice, pojačano znojenje, abnormalna tekstura kose, poremećaj noktiju*
English: Package leaflet: Information for the user Ribavirin Teva Pharma B.V. 400 mg film-coated tablets ribavirin
Croatian: Uputa o lijeku: Informacije za korisnika Ribavirin Teva Pharma B.V. 400 mg filmom obložene tablete ribavirin
English: Female: amenorrhea, menorrhagia, menstrual disorder, vaginal disorder, Male: testicular pain
Croatian: Žene: amenoreja, menoragija, menstrualni poremećaj, vaginalni poremećaj.
English: Polyvinyl alcohol - partly hydrolysed Macrogol / Polyethylene glycol 3350 Titanium dioxide (E171) Talc
Croatian: Ovojnica tablete poli(vinilni alkohol) - djelomično hidrolizirani makrogol/polietilenglikol 3350 titanijev dioksid (E171) talk željezov oksid, crveni željezov oksid, žuti željezov oksid, crni
English: Conjunctival haemorrhage, eye pruritus, keratitis, vision blurred, photophobia
Croatian: konjunktivalno krvarenje, pruritus oka, keratitis, zamagljen vid, fotofobija
English: From pre-treatment to end of long-term follow up among children treated for 24 or 48 weeks, height for age percentiles decreased 1.3 and 9.0 percentiles, respectively.
Croatian: Od razdoblja prije početka liječenja do završetka dugotrajnog praćenja, percentil visine za dob smanjio se za 1,3 percentila u djece liječene 24 tjedna odnosno za 9,0 percentila u djece liječene 48 tjedana.
English: Patients were randomized to receive either ribavirin (800-1,200 mg/day based on weight) plus peginterferon alfa-2b (100 or 150 µg/week based on weight) or ribavirin (800 -1,200 mg/day based on weight) plus interferon alfa-2b (3 MIU TIW).
Croatian: Bolesnici su bili randomizirani tako da su primali ili ribavirin (800-1200 mg na dan ovisno o tjelesnoj težini) s peginterferonom alfa-2b (100 ili 150 μg na tjedan ovisno o tjelesnoj težini) ili ribavirin (800-1200 mg na dan ovisno o tjelesnoj težini) s interferonom alfa-2b (3 MIU triput na tjedan).
English: • Dental and periodontal disorders: Dental and gum disorders have been reported in patients receiving ribavirin in combination with (peg)interferon alfa-2b.
Croatian: • poremećaje zuba i parodonta: u bolesnika koji su primali rabavirin u kombinaciji s (peg)interferonom alfa-2b prijavljeni su poremećaji zuba i desni.
English: For BMI, pre-treatment to end of long-term follow up, BMI for age percentiles decreased 1.8 and 7.5 percentiles among children treated for 24 weeks or 48 weeks, respectively.
Croatian: Kada je u pitanju indeks tjelesne mase (engl. body mass index, BMI), od razdoblja prije početka liječenja do završetka dugotrajnog praćenja percentili na percentilnoj krivulji indeksa tjelesne mase za dob smanjili su se za 1,8 percentila u djece liječene 24 tjedna te za 7,5 percentila u djece liječene 48 tjedana.
English: In a juvenile rat toxicity study, pups dosed from postnatal day 7 to 63 with 10, 25 and 50 mg/kg of ribavirin demonstrated a dose-related decrease in overall growth, which was subsequently manifested as slight decreases in body weight, crown-rump length and bone length.
Croatian: U ispitivanju toksičnosti na mladim štakorima, mladunci su primali ribavirin u dozi od 10, 25 i 50 mg/kg od 7. do 63. dana po okotu.
English: You or your caregiver should call your doctor immediately if you have any of these side effects.
Croatian: Ako imate neku od ovih nuspojava, Vi ili osoba koja skrbi o Vama morate odmah nazvati liječnika.
English: Haemolitic anaemia, leukopenia, thrombocytopenia, lymphadenopathy, lymphopenia
Croatian: anemija, neutropenija hemolitička anemija, leukopenija, trombocitopenija, limfadenopatija, limfopenija vrlo rijetko:
English: The recommended dose and duration of Ribavirin Teva Pharma B.V. depends on patient's weight and on the medicinal product that is used in combination.
Croatian: Preporučena doza i trajanje liječenja lijekom Ribavirin Teva Pharma B.V. ovise o tjelesnoj težini bolesnika i lijeku s kojim se Ribavirin Teva Pharma B.V. primjenjuje u kombinaciji.
English: Hepatomegaly, jaundice, hyperbilirubinemia*
Croatian: Poremećaji jetre i žuči hepatomegalija, žutica, hiperbilirubinemija*
English: A decrease in haemoglobin levels to < 10 g/dL was observed in up to 14 % of adult patients and 7 % of children and adolescents treated with ribavirin in combination with peginterferon alfa-2b or interferon alfa-2b in clinical trials.
Croatian: Sniženje koncentracije hemoglobina na <10 g/dl opaženo je u najviše 14% odraslih bolesnika i 7% djece i adolescenata liječenih ribavirinom u kombinaciji s peginterferonom alfa-2b ili interferonom alfa-2b u kliničkim ispitivanjima.
English: Haematological abnormalities in HCV/HIV co-infected patients:
Croatian: Hematološki poremećaji u bolesnika s istodobnom infekcijom HCV-om i HIV-om:
English: HCV/HIV co-infected patients receiving peginterferon alfa-2b/ribavirin treatment and cART may be at increased risk to develop haematological abnormalities (as neutropenia, thrombocytopenia and anaemia) compared to HCV mono-infected patients.
Croatian: U odnosu na bolesnike inficirane samo HCV-om, bolesnici s istodobnom infekcijom HCV-om i HIV-om koji primaju peginterferon alfa-2b/ribavirin i cART mogu imati povećan rizik za razvoj hematoloških poremećaja (kao što su neutropenija, trombocitopenija i anemija).
English: Previously untreated patients:
Croatian: Bolesnici koji nisu prethodno liječeni
English: Haemoglobin levels dropped below 10 g/dL in up to 14 % of adult patients and 7 % of children and adolescents treated with ribavirin in combination with either peginterferon alfa-2b or interferon alfa2b.
Croatian: Koncentracije hemoglobina pale su na vrijednosti ispod 10 g/dl u najviše 14% odraslih bolesnika i 7% djece i adolescenata liječenih ribavirinom u kombinaciji s peginterferonom alfa-2b ili interferonom alfa-2b.
English: Your doctor has determined the correct dose of this medicine based on how much you or the child you are caring for weighs.
Croatian: Vaše tjelesne težine odnosno tjelesne težine djeteta o kojem skrbite.
English: Very commonly reported side effects (may affect more than 1 in 10 people):
Croatian: Vrlo često prijavljene nuspojave (mogu se javiti u više od 1 na 10 osoba):
English: Suicidal ideation, psychosis, aggressive behaviour, confusion, agitation, anger, mood altered, abnormal behaviour nervousness, sleep disorder, decreased libido, apathy, abnormal dreams, crying.
Croatian: depresija, anksioznost, emocionalna labilnost, nesanica suicidalne misli, psihoza, agresivno ponašanje, konfuzija, agitiranost, ljutnja, promjene raspoloženja, neuobičajeno ponašanje, nervoza, poremećaj spavanja, oslabljen libido, apatija, neuobičajeni snovi, plač manje često:
English: In combination with peginterferon alfa-2b
Croatian: U kombinaciji s peginterferonom alfa-2b
English: Erythrocytes are a primary target of toxicity for ribavirin in animal studies.
Croatian: U istraživanjima na životinjama toksični su učinci ribavirina prvenstveno usmjereni na eritrocite.
English: Please refer to the corresponding SmPC of medicinal products used in combination with ribavirin for further dosage recommendations on co-administration.
Croatian: Molimo pročitajte odgovarajuće Sažetke opisa svojstava lijeka za lijekove koji se primjenjuju u kombinaciji s ribavirinom za dodatne preporuke za doziranje kod njihove istodobne primjene.
English: Very rarely reported side effects (may affect up to 1 in 10,000 people):
Croatian: Vrlo rijetko prijavljene nuspojave (mogu se javiti u do 1 na 10 000 osoba):
English: Ribavirin (800 mg/day) + interferon alfa2b (3 MIU TIW)
Croatian: Ribavirin (800 mg/dan) + interferon alfa-2b (3 MIU triput na tjedan)
English: There are several serious adverse reactions associated with the combination therapy of ribavirin with (peg)interferon alfa.
Croatian: Kombinirana terapija ribavirinom i (peg)interferonom alfa povezuje se s nekoliko ozbiljnih nuspojava.
English: Hypothyroidism, hyperthyroidism
Croatian: Endokrini poremećaji hipotireoza, hipertireoza
English: The following other side effects have also been reported with the combination of this medicine and an alpha interferon product: abnormal thoughts, hearing or seeing images that are not present, altered mental status, disorientation, angioedema (swelling of the hands, feet, ankles, face, lips, mouth, or throat which may cause difficulty in swallowing or breathing), stroke (cerebrovascular events), Vogt-Koyanagi-Harada syndrome (an autoimmune inflammatory disorder affecting the eyes, skin and the membranes of the ears, brain and spinal cord), bronchoconstriction and anaphylaxis (a severe, whole-body allergic reaction), constant cough, eye problems including damage to the retina, obstruction of the retinal artery, inflammation of the optic nerve, swelling of the eye and cotton wool spots (white deposits on the retina), enlarged abdominal area, heartburn, trouble having bowel movement or painful bowel movement, acute hypersensitivity reactions including urticaria (hives), bruises, intense pain in a limb, leg or thigh pain, loss of range of motion, stiffness, sarcoidosis (a disease characterised by persistent fever, weight loss, joint pain and swelling, skin lesions and swollen glands).
Croatian: Kada se ovaj lijek uzimao u kombinaciji s alfa interferonom, prijavljene su i sljedeće ostale nuspojave: neuobičajene misli, opažanje zvukova ili slika koji nisu stvarni, promjena psihičkog stanja, dezorijentiranost, angioedem (oticanje šaka, stopala, gležnjeva, lica, usana, usta ili grla, što može uzrokovati poteškoće pri gutanju ili disanju), moždani udar (cerebrovaskularni događaji), sindrom Vogt-Koyanagi-Harada (autoimuni upalni poremećaj koji zahvaća oči, kožu te ušne, moždane i ovojnice kralježnične moždine), bronhokonstrikcija i anafilaksija (teška alergijska reakcija cijelog organizma), uporan kašalj, tegobe s očima koje uključuju oštećenje mrežnice, opstrukciju mrežnične arterije, upalu očnog živca, oticanje oka i pamučasta krvarenja u mrežnici (bijele nakupine na mrežnici), povećan trbuh, žgaravica, poteškoće kod pražnjenja crijeva ili bolno pražnjenje crijeva, akutne reakcije preosjetljivosti uključujući urtikariju (koprivnjaču), modrice, jaka bol u udovima, bol u nozi ili bedru, smanjen opseg pokreta, ukočenost, sarkoidoza (bolest koju prati stalna vrućica, gubitak tjelesne težine, bol i oticanje zglobova, oštećenja kože i oticanje limfnih čvorova).
English: Usual daily Ribavirin Teva Pharma B.V. dose
Croatian: Uobičajena dnevna doza lijeka Ribavirin Teva Pharma B.V.
English: It may harm them,
Croatian: Prethodno neliječeni bolesnici:
English: abnormal behaviour, emotional disorder, fear, nightmare, bleeding of the mucous membrane that lines the inner surface of the eyelids, blurred vision, drowsiness, intolerance to light, itchy eyes, facial pain, inflamed gums, chest discomfort, difficult breathing, lung infection, nasal discomfort, pneumonia,wheezing, low blood pressure, enlarged liver, painful menstruation, itchy anal area (pinworms or ascarids), blistering rash (shingles), decreased sensitivity to touch, muscle twitching, pain in skin, paleness, peeling of skin, redness, swelling.
Croatian: neuobičajeno ponašanje, emocionalni poremećaj, strah, noćne more, krvarenje iz sluznice koja oblaže unutarnju površinu kapaka, zamagljen vid, pospanost, nepodnošenje svjetla, svrbež očiju, bol lica, upaljene desni, osjećaj nelagode u prsištu, otežano disanje, infekcija pluća, osjećaj nelagode u nosu, upala pluća, piskanje u plućima, nizak krvni tlak, povećana jetra, bolne mjesečnice, svrbež analnog područja (dječje gliste ili askaridi), mjehurićasti pojasasti osip (herpes zoster), smanjena osjetljivost na dodir, grčevi mišića, bol u koži, bljedilo, ljuštenje kože, crvenilo, otekline.
English: In combination with interferon alfa-2b
Croatian: U kombinaciji s interferonom alfa-2b
English: - anti-Human Immunodeficiency Virus (HIV) medicines - [nucleoside reverse transcriptase inhibitor (NRTI), and/or combined anti-retroviral therapy (cART)]: Taking this medicine in combination with an alpha interferon and an anti-HIV medicine may increase the risk of lactic acidosis, liver failure, and blood abnormalities development (reduction in number of red blood cells which carry oxygen, certain white blood cells that fight infection, and blood clotting cells called platelets).
Croatian: Uzimanje ovog lijeka u kombinaciji s alfa interferonom i lijekom protiv HIV-a može povećati rizik od laktacidoze, zatajenja jetre i razvoja poremećaja krvne slike (smanjenja broja crvenih krvnih stanica koje prenose kisik, određenih bijelih krvnih stanica koje se bore protiv infekcije i krvnih pločica koje sudjeluju u zgrušavanju krvi).
English: Tel: +(421) 2 5726 7911
Croatian: Teva Pharmaceuticals Slovakia s.r.o. Tel: +(421) 2 5726 7911
English: Amnesia, memory impairment, syncope, migraine, ataxia,, paraesthaesia, dysphonia, taste loss, hypoaesthesia, hyperaesthesia, hypertonia, somnolence, disturbance in attention, tremor, dysgeusia
Croatian: glavobolja, omaglica, suha usta, narušena koncentracija amnezija, poremećaj pamćenja, sinkopa, migrena, ataksija, parestezija, disfonija, gubitak osjeta okusa, hipoestezija, hiperestezija, hipertonija, somnolencija, poremećaj pažnje, tremor, disgeuzija manje često:
English: Ulcerative stomatitis, stomatitis, mouth ulceration, colitis, upper right quadrant pain, dyspepsia, gastroesophageal reflux*, glossitis, cheilitis, abdominal distension, gingival bleeding, gingivitis, loose stools, tooth disorder, constipation, flatulence
Croatian: proljev, povraćanje, mučnina, bol u abdomenu ulcerozni stomatitis, stomatitis, ulceracije u usnoj šupljini, kolitis, bol u gornjem desnom kvadrantu, dispepsija, gastroezofagealni refluks*, glositis, heilitis, distenzija abdomena, krvarenje iz desni, gingivitis, mekana stolica, poremećaj zuba, konstipacija, flatulencija manje često:
English: Please refer to the corresponding SmPC of medicinal products used in combination with Ribavirin Teva Pharma B.V..
Croatian: Molimo pročitajte odgovarajuće Sažetke opisa svojstava lijeka za lijekove koji se primjenjuju u kombinaciji s lijekom Ribavirin Teva Pharma B.V.
English: How to store Ribavirin Teva Pharma B.V.
Croatian: Kako čuvati Ribavirin Teva Pharma B.V.
English: Rarely reported side effects (may affect up to 1 in 1,000 people):
Croatian: Rijetko prijavljene nuspojave (mogu se javiti u do 1 na 1000 osoba):
English: During combination therapy for up to 48 weeks with interferon alfa2b and ribavirin, growth inhibition was observed that resulted in reduced final adult height in some patients.
Croatian: Za vrijeme kombinirane terapije interferonom alfa-2b i ribavirinom u trajanju do 48 tjedana primijećen je zastoj u rastu.
English: Please refer to the corresponding Summary of Product Characteristics of the antiretroviral medicinal products that are to be taken concurrently with HCV therapy for awareness and management of toxicities specific for each product and the potential for overlapping toxicities with Ribavirin Teva Pharma B.V in combination with other medicinal products.
Croatian: Molimo pročitajte odgovarajuće Sažetke opisa svojstava lijeka za antiretrovirusne lijekove koji će se uzimati istodobno s lijekovima za liječenje HCV-a kako biste saznali koji su toksični učinci specifični za svaki pojedini lijek, kako ih zbrinuti te kolika je mogućnost njihovog preklapanja s toksičnim učincima ribavirina i drugih lijekova.
English: Each tablet contains 400 mg of ribavirin
Croatian: Jedna tableta sadrži 400 mg ribavirina.
English: decreases in the number of red blood cells (that may cause fatigue, shortness of breath, dizziness), decrease in neutrophils(that make you more susceptible to different infections), difficulty concentrating, feeling anxious or nervous, mood swings, feeling depressed or irritable, tired feeling, trouble falling asleep or staying asleep, cough, dry mouth, pharyngitis (sore throat), diarrhoea, dizziness, fever, flu-like symptoms, headache, nausea, shaking chills, virus infection, vomiting, weakness, loss of appetite, loss of weight, stomach pain, dry skin, irritation, hair loss, itching, muscle pain, muscle aches, pain in joints and muscles, rash.
Croatian: smanjenje broja crvenih krvnih stanica (to može uzrokovati umor, nedostatak daha, omaglicu), smanjenje broja neutrofila (zbog čega možete biti osjetljiviji na razne infekcije), poteškoće s koncentracijom, osjećaj tjeskobe ili nervoze, promjene raspoloženja, depresivnost ili razdražljivost, umor, poteškoće s uspavljivanjem ili održavanjem sna, kašalj, suha usta, faringitis (upala grla), proljev, omaglica, vrućica, simptomi nalik gripi, glavobolja, mučnina, tresavica zbog zimice, virusna infekcija, povraćanje, slabost, gubitak teka, gubitak tjelesne težine, bol u trbuhu, suha koža, iritacija, gubitak kose, svrbež, bol u mišićima, bol u zglobovima i mišićima, osip.
English: Headache, dizziness
Croatian: piskanje, nelagoda u nosu
English: Injury, poisoning and procedural complications
Croatian: Ozljede, trovanja i proceduralne komplikacije laceracija kože manje često:
English: Vertigo, hearing impaired/loss, tinnitus, ear pain
Croatian: Poremećaji uha i labirinta vrtoglavica, oštećenje/gubitak sluha, tinitus, bol u uhu
English: How to use Ribavirin Teva Pharma B.V.
Croatian: Kako uzimati Ribavirin Teva Pharma B.V.